Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.

NCT00227461 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Kessler Foundation

Collaborators